PADCEV 20 MG Injection

RxCUI: 2268315
RxNorm name: PADCEV 20 MG Injection
Display name: PADCEV 20 MG Injection
Full name: PADCEV 20 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:17

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761137	Padcev	enfortumab vedotin-ejfv	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PADCEV EJFV	ENFORTUMAB VEDOTIN	SEAGEN INC.	b5631d3e-4604-4363-8f20-11dfc5a4a8ed	2026-08-04	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2268315

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
b5631d3e-4604-4363-8f20-11dfc5a4a8ed	PADCEV 20 MG Injection [PSN] · enfortumab vedotin-ejfv 20 MG Injection [Padcev] [SBD] · Padcev 20 MG Injection [SY]	3	16	These highlights do not include all the information needed to use PADCEV safely and effectively. See full prescribing information for PADCEV. PADCEV ® (enfortumab vedotin-ejfv) for injection, for intravenous use Initial U.S. Approval: 2019	20251121